CAM
Cormorant Asset Management Portfolio holdings
AUM
$1.34B
This Quarter Return
+38.34%
1 Year Return
+85.27%
3 Year Return
+2,244.39%
5 Year Return
+2,846.94%
10 Year Return
+51,155.97%
AUM
$2.28B
AUM Growth
+$2.28B
(+30%)
Cap. Flow
-$48.7M
Cap. Flow
% of AUM
-2.14%
Top 10 Holdings %
Top 10 Hldgs %
42%
Holding
83
New
12
Increased
7
Reduced
50
Closed
3
Top Buys
| 1 |
FMTX
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
|
$153M |
| 2 |
Avidity Biosciences
RNA
|
$67.8M |
| 3 |
Arcturus Therapeutics
ARCT
|
$25.1M |
| 4 |
Pliant Therapeutics
PLRX
|
$18.8M |
| 5 |
BioNTech
BNTX
|
$11.7M |
Top Sells
Sector Composition
| 1 | Healthcare | 93.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BPMC
26
DELISTED
Blueprint Medicines
BPMC
| $27.3M | 1.04% | 350,000 -100,000 | -22% | -$7.8M |
|
27
Ascendis Pharma
ASND
$11.8B
| $25.9M | 0.99% | 175,000 -75,000 | -30% | -$11.1M |
|
|
AXNX
28
DELISTED
Axonics, Inc. Common Stock
AXNX
| $25.3M | 0.97% | 720,397 -79,603 | -10% | -$2.79M |
|
29
Twist Bioscience
TWST
$1.63B
| $25M | 0.96% | 552,849 -134,300 | -20% | -$6.08M |
|
|
IGMS
30
DELISTED
IGM Biosciences
IGMS
| $24.8M | 0.95% | 340,146 -85,958 | -20% | -$6.28M |
|
|
TCDA
31
DELISTED
Tricida, Inc. Common Stock
TCDA
| $24M | 0.91% | 872,137 -5,838 | -0.7% | -$160K |
|
32
Cabaletta Bio
CABA
$133M
| $23.5M | 0.9% | 2,105,844 -2 | -0% | -$22 |
|
|
STSA
33
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $23M | 0.88% | 798,905 -9,477 | -1% | -$273K |
|
34
Beam Therapeutics
BEAM
$1.66B
| $22M | 0.84% | 796,429 | – | – |
|
|
QTNT
35
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $21.5M | 0.82% | 2,900,399 -261,101 | -8% | -$1.93M |
|
36
Zai Lab
ZLAB
$3.68B
| $20.5M | 0.78% | 250,000 -39,092 | -14% | -$3.21M |
|
37
uniQure
QURE
$896M
| $20M | 0.76% | 444,157 +194,157 | +78% | +$8.75M |
|
38
Zymeworks
ZYME
$1.12B
| $19.8M | 0.76% | 550,000 -150,000 | -21% | -$5.41M |
|
39
AnaptysBio
ANAB
$569M
| $19.8M | 0.76% | 885,838 -222,062 | -20% | -$4.96M |
|
40
Galapagos
GLPG
$2.07B
| $19.5M | 0.74% | 99,075 +472 | +0.5% | +$92.8K |
|
|
DCPH
41
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $19M | 0.73% | 318,914 -31,086 | -9% | -$1.86M |
|
|
42
Pliant Therapeutics
PLRX
$101M
| $18.8M | 0.72% | +611,409 | New | +$18.8M |
|
43
Sarepta Therapeutics
SRPT
$1.78B
| $17.6M | 0.67% | 110,000 -40,000 | -27% | -$6.41M |
|
44
argenx
ARGX
$43.6B
| $15.8M | 0.6% | 70,000 -10,000 | -13% | -$2.25M |
|
45
NextCure
NXTC
$13.5M
| $14.9M | 0.57% | 693,971 -49,429 | -7% | -$1.06M |
|
46
Akero Therapeutics
AKRO
$3.74B
| $14.8M | 0.56% | 592,539 -50,000 | -8% | -$1.25M |
|
|
ALLK
47
DELISTED
Allakos
ALLK
| $14.2M | 0.54% | 197,515 -2,485 | -1% | -$179K |
|
48
Inspire Medical Systems
INSP
$2.77B
| $12.9M | 0.49% | 147,982 -2,018 | -1% | -$176K |
|
49
Insmed
INSM
$28.8B
| $12.4M | 0.47% | 450,000 +87,727 | +24% | +$2.42M |
|
|
50
BioNTech
BNTX
$24B
| $11.7M | 0.45% | +175,000 | New | +$11.7M |
|